Neurocrine Biosciences
NBIX
#1455
Rank
S$15.76 B
Marketcap
$156.11
Share price
-2.01%
Change (1 day)
2.17%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of June 2024 : S$1.35 B

According to Neurocrine Biosciences 's latest financial reports the company has S$1.35 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$1.36 B2.73%
2022-12-31S$1.32 B38.26%
2021-12-31S$0.95 B-9.41%
2020-12-31S$1.05 B17.45%
2019-12-31S$0.90 B1.68%
2018-12-31S$0.88 B28.5%
2017-12-31S$0.69 B55.13%
2016-12-31S$0.44 B-17.14%
2015-12-31S$0.53 B109.65%
2014-12-31S$0.25 B38.66%
2013-12-31S$0.18 B-12.77%
2012-12-31S$0.21 B26.63%
2011-12-31S$0.16 B2.27%
2010-12-31S$0.16 B117.6%
2009-12-31S$75.13 M-35.07%
2008-12-31S$0.11 B-55.38%
2007-12-31S$0.25 B-7.37%
2006-12-31S$0.28 B-38.41%
2005-12-31S$0.45 B2.39%
2004-12-31S$0.44 B-42.43%
2003-12-31S$0.77 B81.64%
2002-12-31S$0.42 B-28.32%
2001-12-31S$0.59 B107.55%
2000-12-31S$0.28 B88.16%
1999-12-31S$0.15 B685.24%
1998-12-31S$19.31 M-27.49%
1997-12-31S$26.63 M68.45%
1996-12-31S$15.81 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.05 B-22.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.32 B 145.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$13.04 M-99.04%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.38 B 223.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.13 B 1,166.44%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.24 B 583.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.32 B-76.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.32 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA